Product NDC: | 55390-066 |
Proprietary Name: | Dicyclomine Hydrochloride |
Non Proprietary Name: | Dicyclomine Hydrochloride |
Active Ingredient(s): | 10 mg/mL & nbsp; Dicyclomine Hydrochloride |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-066 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040465 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030717 |
Package NDC: | 55390-066-10 |
Package Description: | 10 VIAL in 1 BOX (55390-066-10) > 2 mL in 1 VIAL |
NDC Code | 55390-066-10 |
Proprietary Name | Dicyclomine Hydrochloride |
Package Description | 10 VIAL in 1 BOX (55390-066-10) > 2 mL in 1 VIAL |
Product NDC | 55390-066 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dicyclomine Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20030717 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | DICYCLOMINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |